6-arylamino-5-cyano-4-pyrimidinones as pde9a inhibitors

Abstract

The invention relates to novel 6-arylamino-5-cyano-4-pyrimidinones of formula (I) methods for the production thereof, and the use thereof for producing medicaments utilized for improving awareness, concentration, learning capacity, and/or retentiveness of memory. Said compounds (I) show activity as PDE9 inhibitors.

1 . A compound of formula 
     
       
         
         
             
             
         
       
     
     in which
 A is C 1 -C 8 -alkyl, C 3 -C 8 -cycloalkyl, tetrahydrofuryl or tetrahydropyranyl, which are optionally substituted by up to 3 radicals independently of one another selected from the group of C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, hydroxycarbonyl, cyano, trifluoromethyl, trifluoromethoxy, amino, hydroxy, C 1 -C 6 -alkylamino, halogen, C 1 -C 6 -alkylaminocarbonyl, C 1 -C 6 -alkoxycarbonyl, C 1 -C 6 -alkylcarbonyl, C 1 -C 6 -alkylsulfonyl and C 1 -C 6 -alkylthio,
 where C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -alkylamino, C 1 -C 6 -alkylaminocarbonyl, C 1 -C 6 -alkoxycarbonyl, C 1 -C 6 -alkylcarbonyl, C 1 -C 6 -alkylsulfonyl and C 1 -C 6 -alkylthio are optionally substituted by one or more radicals selected from the group of hydroxy, cyano, halogen, hydroxycarbonyl and a group of the formula —NR 3 R 4 ,
 where 
 R 3  and R 4  are independently of one another hydrogen or C 1 -C 6 -alkyl, 
 or 
 R 3  and R 4  together with the nitrogen atom to which they are bonded are 5- to 8-membered heterocyclyl, 
 
 
 B is phenyl or heteroaryl which are optionally substituted by up to 3 radicals independently of one another selected from the group of C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, hydroxycarbonyl, cyano, trifluoromethyl, trifluoromethoxy, amino, nitro, hydroxy, C 1 -C 6 -alkylamino, halogen, C 1 -C 6 -alkylaminocarbonyl, C 1 -C 6 -alkoxycarbonyl, C 1 -C 6 -alkylcarbonyl, C 1 -C 6 -alkylsulfonyl and C 1 -C 6 -alkylthio,
 where C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -alkylamino, C 1 -C 6 -alkylaminocarbonyl, C 1 -C 6 -alkoxycarbonyl, C 1 -C 6 -alkylcarbonyl, C 1 -C 6 -alkylsulfonyl and C 1 -C 6 -alkylthio are optionally substituted by a radical selected from the group of hydroxy, cyano, halogen, hydroxycarbonyl and a group of the formula —NR 3 R 4 ,
 where 
 R 3  and R 4  have the abovementioned meanings, 
 
 
 or salts, solvates and/or solvates of the salts thereof. 
 
   
   
       2 . A compound as claimed in  claim 1 , where
 A is C 1 -C 5 -alkyl or C 3 -C 6 -cycloalkyl, which are optionally substituted by up to 3 radicals independently of one another selected from the group of C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, hydroxycarbonyl, cyano, amino, hydroxy, C 1 -C 4 -alkylamino, fluorine, chlorine, bromine, C 1 -C 4 -alkoxycarbonyl, C 1 -C 6 -alkylcarbonyl, C 1 -C 4 -alkylsulfonyl and C 1 -C 4 -alkylthio,
 where C 1 -C 4 -alkyl and C 1 -C 4 -alkoxy are optionally substituted by a radical selected from the group of hydroxy, cyano, fluorine, chlorine, bromine, hydroxycarbonyl and a group of the formula —NR 3 R 4 ,
 where 
 R 3  and R 4  are independently of one another hydrogen or C 1 -C 4 -alkyl, 
 or 
 R 3  and R 4  together with the nitrogen atom to which they are bonded are 5- to 6-membered heterocyclyl, 
 
   B is phenyl, thienyl or pyridyl, which are optionally substituted by up to 3 radicals in each case independently of one another selected from the group of C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, hydroxycarbonyl, cyano, trifluoromethyl, trifluoromethoxy, amino, hydroxy, C 1 -C 4 -alkylamino, fluorine, chlorine, bromine, C 1 -C 4 -alkylaminocarbonyl, C 1 -C 4 -alkoxycarbonyl, C 1 -C 4 -alkylcarbonyl, C 1 -C 4 -alkylsulfonyl and C 1 -C 4 -alkylthio,
 where C 1 -C 4 -alkyl and C 1 -C 4 -alkoxy are optionally substituted by a radical selected from the group of hydroxy, cyano, fluorine, chlorine, bromine, hydroxycarbonyl and a group of the formula NR 3 R 4  
 where 
 R 3  and R 4  have the abovementioned meanings, 
 
   or salts, solvates and/or solvates of the salts thereof.   
   
   
       3 . A compound as claimed in  claim 1 , where
 A is C 3 -C 5 -alkyl or C 5 -C 6 -cycloalkyl,   B is phenyl, thienyl or pyridyl, which are optionally substituted by up to 3 radicals in each case independently of one another selected from the group of C 1 -C 3 -alkyl, trifluoromethyl, hydroxy, methoxy, ethoxy, cyano, dimethylamino, diethylamino, methoxycarbonyl, ethoxycarbonyl, methylcarbonyl, ethylcarbonyl, fluorine and chlorine,   or salts, solvates and/or solvates of the salts thereof.   
   
   
       4 . A process for preparing compounds of the formula (I), characterized in that compounds of formula 
     
       
         
         
             
             
         
       
     
     are initially converted with a compound of the formula
   H 2 N—B  (III) 
 
     in which
 B has the meanings stated in  claim 1 , 
 at elevated temperature in an inert solvent or else in the absence of a solvent into a compound of formula 
 
     
       
         
         
             
             
         
       
     
     in which
 B has the meanings stated in  claim 1 , 
 and the latter is then reacted in an inert solvent in the presence of a base with a compound of the formula 
 
     
       
         
         
             
             
         
       
     
     in which
 A has the meanings stated in  claim 1 , 
 and the resulting compounds of formula (I) are reacted where appropriate with the appropriate (i) solvents and/or (ii) bases or acids to give their solvates, salts and/or solvates of the salts. 
 
   
   
       5 . A medicament comprising at least one of the compounds as claimed in  claim 1  and at least one pharmaceutically acceptable, essentially nontoxic carrier or excipient. 
   
   
       6 . A method for improving perception, concentration, learning and/or memory comprising administering to a human or animal an effective amount of a compound of  claim 1 . 
   
   
       7 . A method for treating impairments of perception, concentration, learning and/or memory comprising administering to a human or animal an effective amount of a compound of  claim 1 . 
   
   
       8 . The method as claimed in  claim 7 , where the impairment is a consequence of Alzheimer's disease.